mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0003 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0004 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0004 |